Position in CGON
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$19,543,006
+$11,801,686 QoQ
Shares Held
288,756
+54.9% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. CGON ranks #13 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
350,923 | $271,137,146 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,195 | $101,898,194 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,848 | $93,255,047 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,168,666 | $75,530,883 | |
| 5 | ARGX |
Argenx SE
|
80,824 | $59,021,726 | |
| 6 | ASND |
Ascendis Pharma A/S
|
217,992 | $49,861,310 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
529,954 | $39,794,245 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
317,811 | $30,907,119 |
All Filings in CGON
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,543,006 | 288,756 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,741,320 | 186,448 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,089,369 | 151,176 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,300,672 | 203,872 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,672,813 | 68,306 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,270,997 | 79,184 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,672,642 | 70,836 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,938,661 | 93,084 | Shares | Sole | 2024-08-02 | |
| No filing history on record for this holder in this stock. | ||||||